- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
| (1) | Registration Statement (Form S-8 No. 333-206335) pertaining to the vTv Therapeutics Inc. 2015 Omnibus Equity Incentive Plan; |
| (2) | Registration Statement (Form S-3 No. 333-232571) of vTv Therapeutics Inc.; |
| (3) | Registration Statement (Form S-8 No. 333-240304) of vTv Therapeutics Inc.; |
| (4) | Registration Statement (Form S-1 No. 333-250934) of vTv Therapeutics Inc.; |
| (6) | Registration Statement (Form S-3 No. 333-256755) of vTv Therapeutics Inc. |
of our report dated March 29, 2022 with respect to the consolidated financial statements of vTv Therapeutics Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2021.
/s/ Ernst & Young LLP
Raleigh, North Carolina
March 29, 2022